A Little About Us…
As we work to increase engagement with our stakeholders and members of the public who are interested in the work that we do, we thought it would be a good idea to share a little about us. Acuitas Therapeutics is a Vancouver-based biotechnology company that works with partners to develop new therapies to address unmet clinical needs based on our internationally recognized capabilities in delivery technology. We were founded in February 2009 and have grown substantially from our modest start to today, where we have the absolute honour to work with some of the best organizations in the world.
Acuitas is a private company that specializes in the development of lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics. We partner with pharmaceutical companies, biotechnology organizations and academic institutes to advance nucleic acid therapeutics to the clinical trial phase and to the marketplace.
Over the past 11 years, we have developed an exceptional reputation in the field of lipid nanotechnology. Our team, led by founder Dr. Thomas Madden, is made up of highly experienced researchers, scientists, project managers and administrative professionals – all of whom are focused on excellence in their respective roles and as a company. We’re really proud of our company, the values that are at the foundation of every action that we take, and the work that we do.
Our next blog post will talk a bit about the work that we are doing with our partners to develop mRNA COVID-19 vaccines.